Our Latest News
Stay up to date on our latest research and more!
Categories
Precision Epigenomics Presents Validation of EPISEEK™, a Multi-Cancer Early Detection Test, at 2025 ASCO Annual Meeting
The data support the EPISEEK™ test’s potential as an accurate and cost-effective solution for...
Precision Epigenomics Highlighted by Tucson News 13 for Multi-Cancer Early Detection Blood Test Development
Tucson’s News 13 recently highlighted Precision Epigenomic’s groundbreaking work developing...
Precision Epigenomics Shares Abstracts Showing Performance of Assays for Melanoma and Brain Cancer Detection
Precision Epigenomics announced that the company presented data supporting the critical role of...
Precision Epigenomics Announces Closing of $1.5M Series A1 Funding
With this funding, Precision Epigenomics has raised more than $3.9M in investments helping move...
Precision Epigenomics Receives $2M Award from National Institutes of Health
This award will lead to the development of EPISEEK-MPE, a multi-cancer detection test, using...
2024 Flinn Foundation Bioscience Entrepreneurship Program Partner
Precision Epigenomics Inc. announced today that it was selected by...
Annual Association For Molecular Pathology Presentation
Precision Epigenomics Inc. presents a bioinformatics study...
Digestive Disease Week Presentation
Precision Epigenomics Inc. presents a pilot study of the performance of EPISEEK™ for...
Multi-Cancer Detection Assay on Pleural Fluid Publication
Precision Epigenomics Inc. announced the publication of scientific data demonstrating the diagnostic efficiency of its multi-cancer detection...
American Thoracic Society Presentation
Precision Epigenomics Inc. presents results of the performance of the EPISEEK-MPE™ test at the...